STEPHANIE HUBBARD: Open Payments
NPI 1871003988 · HOUSTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 24 payments from 6 companies in 2025. Trend: 2023 $302 · 2024 $936 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $269 |
| Novartis Pharmaceuticals Corporation | 6 | $86 |
| UCB, Inc. | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 2 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: SKYRIZI, RINVOQ, COSENTYX, Bimzelx, PURIFIED CORTROPHIN GEL, ACTHAR, TREMFYA.
Industry payments across MS — which companies pay providers there.
